NCT05238883 2025-11-21A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsHiFiBiO TherapeuticsPhase 1 Active not recruiting72 enrolled
NCT03744468 2025-10-02Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid TumorsBeiGenePhase 1/2 Completed114 enrolled